The ready-to-use lentiviral particles of Lenti-MAGE-A3 TCR (6F9)-VP is packaged using 3rd generation of lentiviral packaging system, in which the gene of Murinized TCR will be driven by a CMV promotor. The target gene of TCR packaged in lentiviral particles could be used for high efficency tranduction of T cells and stably integrated expression.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|VP-TCR-C246||Lenti-MAGE-A3 T cell receptor (TCRVα38/Vβ2) Viral Particle|
|VP-TCR-C245||Lenti-MAGE-A3 T cell receptor (ESBI 648) Viral Particle|
|VP-TCR-C252||Lenti-MAGE-A3 Murinized T cell receptor (R12C9) Viral Particle|
|TCR-C126Z||Human anti-MAGE-A3 T cell receptor (6F9), pCDTCR1|
|VP-TCR-C244||Lenti-MAGE-A3 T cell receptor (R12C9) Viral Particle|
|TCR-C128Z||Human anti-MAGE-A3 T cell receptor (ESBI 648), pCDTCR1|
|TCR-L059Z||Murinized anti-MAGEA3 (aa243-258) T cell receptor, pCDTCR1|
|VP-TCR-C247||Lenti-MAGE-A3 T cell receptor (TCRVα3/Vβ28) Viral Particle|
|TCR-L245||Human anti-MAGE-A3 T cell receptor, pCDTCR1|
|TCR-L362||Murinized anti-MAGE-A3 T cell receptor (6F9), pCDTCR1|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved